Cargando…
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC
BACKGROUND: The development of drug resistance and high mortality rates are the major problems observed in non-small cell lung cancer (NSCLC). Biomarkers indicating and predicting disease development towards these unfavorable directions are therefore on high demand. Many studies have demonstrated th...
Autores principales: | Simiene, Julija, Dabkeviciene, Daiva, Stanciute, Diana, Prokarenkaite, Rimvile, Jablonskiene, Valerija, Askinis, Renatas, Normantaite, Kamile, Cicenas, Saulius, Suziedelis, Kestutis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496384/ https://www.ncbi.nlm.nih.gov/pubmed/37697308 http://dx.doi.org/10.1186/s12885-023-11365-5 |
Ejemplares similares
-
LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer
por: Vezelis, Alvydas, et al.
Publicado: (2021) -
Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R
por: Farhana, Lulu, et al.
Publicado: (2013) -
MiR-630 suppresses breast cancer progression by targeting metadherin
por: Zhou, Ci-Xiang, et al.
Publicado: (2015) -
Components of NOTCH Signaling for Uterine Cancer Patients' Prognosis
por: Lachej, Nadezda, et al.
Publicado: (2022) -
miR-630 functions as a tumor oncogene in renal cell carcinoma
por: Zhao, Jian-Jun, et al.
Publicado: (2016)